Fungal Infections Associated With the Use of Novel Immunotherapeutic Agents-Reference-Cited by-同舟云学术

Fungal Infections Associated With the Use of Novel Immunotherapeutic Agents

Published:2020-09-26 Issue:4 Volume:7 Page:142-149
ISSN:2196-5471
Container-title:Current Clinical Microbiology Reports
language:en
Short-container-title:Curr Clin Micro Rpt

Author:

Bernardes Marilia^ORCID,Hohl Tobias M.

Funder

Memorial Sloan-Kettering Cancer Center

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40588-020-00154-4.pdf

Reference63 articles.

1. Li D, Li X, Zhou W-L, et al. Genetically engineered T cells for cancer immunotherapy. Signal Transduct Target Ther. 2019;4:35.

2. Darvin P, Toor SM, Sasidharan Nair V, Elkord E. Immune checkpoint inhibitors: recent progress and potential biomarkers. Exp Mol Med. 2018;50:165.

3. Neelapu SS, Tummala S, Kebriaei P, Wierda W, Gutierrez C, Locke FL, et al. Chimeric antigen receptor T-cell therapy — assessment and management of toxicities. Nat Rev Clin Oncol. 2018;15:47–62.

4. Brahmer JR, Lacchetti C, Schneider BJ, Atkins MB, Brassil KJ, Caterino JM, et al. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2018;36:1714–68.

5. Patil NK, Guo Y, Luan L, Sherwood ER Targeting Immune Cell Checkpoints During Sepsis https://pubmed.ncbi.nlm.nih.gov/29135922/. Accessed 1 Mar 2020.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint inhibitor increased mortality in lung cancer patients with Pneumocystis jirovecii pneumonia: a comparative retrospective cohort study;Frontiers in Oncology;2024-07-05

2. Fusarium species,Scedosporium species, and Lomentospora prolificans: A systematic review to inform the World Health Organization priority list of fungal pathogens;Medical Mycology;2024-06

3. New anticancer therapeutics impact fungal pathobiology, infection dynamics, and outcome;PLOS Pathogens;2023-12-21

4. Pluronic F-127 Enhances the Antifungal Activity of Fluconazole against Resistant Candida Strains;ACS Infectious Diseases;2023-12-18

5. Atypical imaging patterns during lung invasive mould diseases: lessons for clinicians;European Respiratory Review;2023-09-27